Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • CluePoints Opens New AsiaPac Office in Tokyo

    Dec 16, 2020, 14:13 PM by
    CluePoints, the premier provider of Central Statistical Monitoring, Risk-Based Quality Management and Data Quality Oversight Software for clinical trials, today announced further expansion in Japan with the opening of a new office in Tokyo. Dedicated to serving their Japanese clients, the new office builds on CluePoints’ presence in the region, as demand for modern analytical software and services enabling proactive and exhaustive identification of clinical study quality issues continues to grow. The new location, along with a team located in Osaka, will strengthen CluePoints’ growing reputation within Japan and bring it closer to its Asia-Pacific region customers.
    Full story
  • NanoSyrinx strengthens board with appointment of Dr Jane Dancer as Non-Executive Director

    Dec 16, 2020, 14:12 PM by
    NanoSyrinx announces the appointment of Dr Jane Dancer to its Board as Non-Executive Director. Dr Dancer has over 30 years’ experience in business development across biotech, pharma and agrochemicals and her experience will help to drive NanoSyrinx’s ongoing fundraising activities and ambitious growth plans.
    Full story
  • THREAD Joins Leading Life Sciences Organizations to Advance Decentralized Clinical Research

    Dec 16, 2020, 14:12 PM by
    THREAD, an innovative technology and service provider that enables decentralized clinical research, joins a formidable alliance of 50 life sciences and healthcare organizations to accelerate the broad adoption of patient-focused decentralized clinical trials and research.
    Full story
  • Optibrium Inspires the Next Generation of Scientists with Practical Industry Experience

    Dec 16, 2020, 14:12 PM by
    Student placement to provide invaluable commercial insight and hands-on experience. The educational programme now in its fifth year
    Full story
  • Resolve Biosciences Launches New Era in Single-Cell Spatial Analysis

    Dec 16, 2020, 14:12 PM by
    Resolve Biosciences today announced the completion of a $24 million Series A financing round and the appointment of Co-founder Jason T. Gammack as CEO
    Full story
  • Alpha Solway honours top doctor with new ‘People’s Choice’ award

    Dec 16, 2020, 14:12 PM by
    Scottish kidney specialist named winner at Scottish Health Awards for crucial work during coronavirus outbreak.
    Full story
  • The Boston Globe Names Kyruus a Top Place to Work for 2020

    Dec 16, 2020, 14:11 PM by
    Full story
  • Protheragen Offers Acquisition Opportunity for A Complete Pentapeptide Library

    Dec 16, 2020, 14:11 PM by
    Full story
  • Data Analysis at AI & Medicine: PrediXcan Based Analysis and BSLMM Prediction

    Dec 16, 2020, 14:11 PM by
    Full story
  • Alfa Chemistry Testing Lab: Pharmaceutical Impurity Testing Services to Assist Drug Development

    Dec 16, 2020, 14:11 PM by
    Full story
  • Creative BioMart Supports Immunology Study with a Wide Selection of Adaptive Immunity Proteins

    Dec 16, 2020, 14:11 PM by
    Full story
  • Page & Page and Partners appoints two new creatives following successful 2020

    Dec 16, 2020, 14:10 PM by
    London, UK. 14th December 2020: Page & Page and Partners, the global creative communications agency specialising in health, wellness, and lifestyle, is today announcing the appointment of two new full-time staff. The new joiners are: Kirstie Turner – Writer and editor and Georgie Epps – Mid weight creative.
    Full story
  • Plus Therapeutics Completes Sixth Dosing Cohort in ReSPECT™

    Dec 16, 2020, 14:10 PM by
    Full story
  • IntelyCare Announces Record Growth and Momentum; Meets Surging Demand for Nursing Professionals in Post-Acute Space with Industry-Leading Data Science Approach

    Dec 16, 2020, 14:10 PM by
    IntelyCare reports record growth in 2020 amid surging demand for data science-driven staffing technology in the post-acute market.
    Full story
  • Grant awarded to Qlucore to aid clinical diagnostics of cancer

    Dec 16, 2020, 14:10 PM by
    Qlucore, leading software provider of powerful visualization-based bioinformatics data analysis tools for research and precision diagnostics, is working with leading scientific experts at Lund University (Sweden), Gothenburg University (Sweden) and in China to develop new diagnostics methods and software solutions to significantly improve disease stratification and treatment selection of patients diagnosed with cancer.
    Full story
  • Hendrick Health Deploys 2bPrecise Precision Health Platform

    Dec 16, 2020, 14:10 PM by
    Full story
  • Samsung Biologics breaks ground on Super Plant, the world’s largest and most innovative bio-manufacturing facility

    Dec 16, 2020, 14:10 PM by
    Full story
  • Idifarma partners with industry expert to strengthen spray drying expertise

    Dec 16, 2020, 14:10 PM by
    Full story
  • Sterling announces strategic investment in ADC Biotechnology

    Dec 16, 2020, 14:10 PM by
    Full story
  • iVexSol Announces Series A Funding

    Dec 16, 2020, 14:10 PM by
    iVexSol, a Worcester, MA-based manufacturer of lentiviral vector (LVV), announced a $13.0M Series A funding round. LVV is a critical raw material in the development of important new cell and gene therapies. iVexSol’s technology can reliably produce LVV at significantly greater quantities than traditional processes, enabling a smaller manufacturing footprint, and facilitating the rapid scale-out needed for global demand. The funding will be used to establish a cGMP manufacturing facility in Lexington, MA.
    Full story
  • «
  • 201
  • 202
  • 203 (current)
  • 204
  • 205
  • 206
  • 207
  • 208
  • 209
  • 210
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy